Comparison of GlideScope Videolaryngoscopy to Direct Laryngoscopy for Nasal Intubation

Nasal Intubation Clinical Trial

Official title:

Comparison of GlideScope Videolaryngoscopy to Direct Laryngoscopy for Nasal Intubation

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT00400972
• Other study ID #: R-06-467
• Secondary ID: HSREB 12719
• Status: Completed
• Phase: N/A
• Start date: November 2006
• Est. completion date: September 2007

Study information

• Verified date: September 2007
• Source: Lawson Health Research Institute
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The purpose of this study is to determine whether nasal intubation assisted by GlideScope videolaryngoscopy is faster, easier, and less traumatic than nasal intubation with conventional direct laryngoscopy.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 70
• Est. completion date: September 2007
• Est. primary completion date: September 2007
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• any patient who is at least 18 years old

• patient requires nasal intubation for surgical indications

• operator has performed at least 10 prior GlideScope intubations (oral or nasal)

Exclusion Criteria:

• cervical spine abnormalities

• known difficult airway

• requires rapid sequence induction

• any other patient in whom the attending anesthesiologist believes usage of the GlideScope is contraindicated

Related Conditions & MeSH terms

• Nasal Intubation

Intervention

Device:
• GlideScope videolaryngoscope

Locations

Country	Name	City	State
Canada	London Health Sciences Centre	London	Ontario

Sponsors (2)

Lead Sponsor	Collaborator
Lawson Health Research Institute	London Health Sciences Centre

Country where clinical trial is conducted

Canada, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	time to intubation
Secondary	ease of intubation (VAS)
Secondary	incidence of trauma
Secondary	number of failures
Secondary	severity of patient sore throat on post-operative day 1